Selected research
Industry Research
Breast AI-assisted Diagnosis Solution Industry Research Report 2026
Market perspective
The global Breast AI-assisted Diagnosis Solution market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the Breast AI-assisted Diagnosis Solution market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Breast AI-assisted Diagnosis Solution market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Breast AI-assisted Diagnosis Solution market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Breast AI-assisted Diagnosis Solution include Yizhun, Sense Time, United Imaging, Huiying Medical, BioMind, Infervision, Demetics Medical, GE HealthCare and Kheiron, among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global Breast AI-assisted Diagnosis Solution market in terms of revenue (US$ million) and, where applicable, service volume (k units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Breast AI-assisted Diagnosis Solution.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Breast AI-assisted Diagnosis Solution Market by Company
Yizhun
Sense Time
United Imaging
Huiying Medical
BioMind
Infervision
Demetics Medical
GE HealthCare
Kheiron
Hologic
Densitas
Lunit Inc.
Breast AI-assisted Diagnosis Solution Segment by Type
Cloud-based
On-Primes
Breast AI-assisted Diagnosis Solution Segment by Application
Hospital
Clinic
Imaging Center
Breast AI-assisted Diagnosis Solution Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Breast AI-assisted Diagnosis Solution market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Breast AI-assisted Diagnosis Solution and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Breast AI-assisted Diagnosis Solution.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Breast AI-assisted Diagnosis Solution companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Cloud-based
- On-Primes
Applications
- Hospital
- Clinic
- Imaging Center
Companies covered
- Yizhun
- Sense Time
- United Imaging
- Huiying Medical
- BioMind
- Infervision
- Demetics Medical
- GE HealthCare
- Kheiron
- Hologic
- Densitas
- Lunit Inc.
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Breast AI-assisted Diagnosis Solution by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Cloud-based
- 2.2.3 On-Primes
- 2.3 Breast AI-assisted Diagnosis Solution by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Hospital
- 2.3.3 Clinic
- 2.3.4 Imaging Center
- 2.4 Assumptions and Limitations
3 Breast AI-assisted Diagnosis Solution Breakdown Data by Type
- 3.1 Global Breast AI-assisted Diagnosis Solution Historic Market Size by Type (2021-2026)
- 3.2 Global Breast AI-assisted Diagnosis Solution Forecasted Market Size by Type (2027-2032)
4 Breast AI-assisted Diagnosis Solution Breakdown Data by Application
- 4.1 Global Breast AI-assisted Diagnosis Solution Historic Market Size by Application (2021-2026)
- 4.2 Global Breast AI-assisted Diagnosis Solution Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Breast AI-assisted Diagnosis Solution Market Perspective (2021-2032)
- 5.2 Global Breast AI-assisted Diagnosis Solution Growth Trends by Region
- 5.2.1 Global Breast AI-assisted Diagnosis Solution Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Breast AI-assisted Diagnosis Solution Historic Market Size by Region (2021-2026)
- 5.2.3 Breast AI-assisted Diagnosis Solution Forecasted Market Size by Region (2027-2032)
- 5.3 Breast AI-assisted Diagnosis Solution Market Dynamics
- 5.3.1 Breast AI-assisted Diagnosis Solution Industry Trends
- 5.3.2 Breast AI-assisted Diagnosis Solution Market Drivers
- 5.3.3 Breast AI-assisted Diagnosis Solution Market Challenges
- 5.3.4 Breast AI-assisted Diagnosis Solution Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Breast AI-assisted Diagnosis Solution Players by Revenue
- 6.1.1 Global Top Breast AI-assisted Diagnosis Solution Players by Revenue (2021-2026)
- 6.1.2 Global Breast AI-assisted Diagnosis Solution Revenue Market Share by Players (2021-2026)
- 6.2 Global Breast AI-assisted Diagnosis Solution Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Breast AI-assisted Diagnosis Solution Head Office and Area Served
- 6.4 Global Breast AI-assisted Diagnosis Solution Players, Product Type & Application
- 6.5 Global Breast AI-assisted Diagnosis Solution Manufacturers Established Date
- 6.6 Global Breast AI-assisted Diagnosis Solution Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Breast AI-assisted Diagnosis Solution Market Size (2021-2032)
- 7.2 North America Breast AI-assisted Diagnosis Solution Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Breast AI-assisted Diagnosis Solution Market Size by Country (2021-2026)
- 7.4 North America Breast AI-assisted Diagnosis Solution Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Breast AI-assisted Diagnosis Solution Market Size (2021-2032)
- 8.2 Europe Breast AI-assisted Diagnosis Solution Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Breast AI-assisted Diagnosis Solution Market Size by Country (2021-2026)
- 8.4 Europe Breast AI-assisted Diagnosis Solution Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Breast AI-assisted Diagnosis Solution Market Size (2021-2032)
- 9.2 Asia-Pacific Breast AI-assisted Diagnosis Solution Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Breast AI-assisted Diagnosis Solution Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Breast AI-assisted Diagnosis Solution Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Breast AI-assisted Diagnosis Solution Market Size (2021-2032)
- 10.2 South America Breast AI-assisted Diagnosis Solution Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Breast AI-assisted Diagnosis Solution Market Size by Country (2021-2026)
- 10.4 South America Breast AI-assisted Diagnosis Solution Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Breast AI-assisted Diagnosis Solution Market Size (2021-2032)
- 11.2 Middle East & Africa Breast AI-assisted Diagnosis Solution Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Breast AI-assisted Diagnosis Solution Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Breast AI-assisted Diagnosis Solution Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 Yizhun
- 12.1.1 Yizhun Company Information
- 12.1.2 Yizhun Business Overview
- 12.1.3 Yizhun Revenue in Breast AI-assisted Diagnosis Solution Business (2021-2026)
- 12.1.4 Yizhun Breast AI-assisted Diagnosis Solution Product Portfolio
- 12.1.5 Yizhun Recent Developments
- 12.2 Sense Time
- 12.2.1 Sense Time Company Information
- 12.2.2 Sense Time Business Overview
- 12.2.3 Sense Time Revenue in Breast AI-assisted Diagnosis Solution Business (2021-2026)
- 12.2.4 Sense Time Breast AI-assisted Diagnosis Solution Product Portfolio
- 12.2.5 Sense Time Recent Developments
- 12.3 United Imaging
- 12.3.1 United Imaging Company Information
- 12.3.2 United Imaging Business Overview
- 12.3.3 United Imaging Revenue in Breast AI-assisted Diagnosis Solution Business (2021-2026)
- 12.3.4 United Imaging Breast AI-assisted Diagnosis Solution Product Portfolio
- 12.3.5 United Imaging Recent Developments
- 12.4 Huiying Medical
- 12.4.1 Huiying Medical Company Information
- 12.4.2 Huiying Medical Business Overview
- 12.4.3 Huiying Medical Revenue in Breast AI-assisted Diagnosis Solution Business (2021-2026)
- 12.4.4 Huiying Medical Breast AI-assisted Diagnosis Solution Product Portfolio
- 12.4.5 Huiying Medical Recent Developments
- 12.5 BioMind
- 12.5.1 BioMind Company Information
- 12.5.2 BioMind Business Overview
- 12.5.3 BioMind Revenue in Breast AI-assisted Diagnosis Solution Business (2021-2026)
- 12.5.4 BioMind Breast AI-assisted Diagnosis Solution Product Portfolio
- 12.5.5 BioMind Recent Developments
- 12.6 Infervision
- 12.6.1 Infervision Company Information
- 12.6.2 Infervision Business Overview
- 12.6.3 Infervision Revenue in Breast AI-assisted Diagnosis Solution Business (2021-2026)
- 12.6.4 Infervision Breast AI-assisted Diagnosis Solution Product Portfolio
- 12.6.5 Infervision Recent Developments
- 12.7 Demetics Medical
- 12.7.1 Demetics Medical Company Information
- 12.7.2 Demetics Medical Business Overview
- 12.7.3 Demetics Medical Revenue in Breast AI-assisted Diagnosis Solution Business (2021-2026)
- 12.7.4 Demetics Medical Breast AI-assisted Diagnosis Solution Product Portfolio
- 12.7.5 Demetics Medical Recent Developments
- 12.8 GE HealthCare
- 12.8.1 GE HealthCare Company Information
- 12.8.2 GE HealthCare Business Overview
- 12.8.3 GE HealthCare Revenue in Breast AI-assisted Diagnosis Solution Business (2021-2026)
- 12.8.4 GE HealthCare Breast AI-assisted Diagnosis Solution Product Portfolio
- 12.8.5 GE HealthCare Recent Developments
- 12.9 Kheiron
- 12.9.1 Kheiron Company Information
- 12.9.2 Kheiron Business Overview
- 12.9.3 Kheiron Revenue in Breast AI-assisted Diagnosis Solution Business (2021-2026)
- 12.9.4 Kheiron Breast AI-assisted Diagnosis Solution Product Portfolio
- 12.9.5 Kheiron Recent Developments
- 12.10 Hologic
- 12.10.1 Hologic Company Information
- 12.10.2 Hologic Business Overview
- 12.10.3 Hologic Revenue in Breast AI-assisted Diagnosis Solution Business (2021-2026)
- 12.10.4 Hologic Breast AI-assisted Diagnosis Solution Product Portfolio
- 12.10.5 Hologic Recent Developments
- 12.11 Densitas
- 12.11.1 Densitas Company Information
- 12.11.2 Densitas Business Overview
- 12.11.3 Densitas Revenue in Breast AI-assisted Diagnosis Solution Business (2021-2026)
- 12.11.4 Densitas Breast AI-assisted Diagnosis Solution Product Portfolio
- 12.11.5 Densitas Recent Developments
- 12.12 Lunit Inc.
- 12.12.1 Lunit Inc. Company Information
- 12.12.2 Lunit Inc. Business Overview
- 12.12.3 Lunit Inc. Revenue in Breast AI-assisted Diagnosis Solution Business (2021-2026)
- 12.12.4 Lunit Inc. Breast AI-assisted Diagnosis Solution Product Portfolio
- 12.12.5 Lunit Inc. Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst